DPAM
RMD icon

Degroof Petercam Asset Management’s ResMed RMD Stock Holding History

Degroof Petercam Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$9.21M Sell
46,527
-4,700
-9% -$861K 0.11% 135
2023
Q4 		$8.81M Buy
+51,227
New +$7.87M 0.12% 144

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Degroof Petercam Asset Management's RMD Position: Q1 2024 in Review

Degroof Petercam Asset Management reduced its ResMed (RMD) stake by 9.2% in Q1 2024, selling an estimated $861K and leaving 46,527 shares worth $9.21M. The position accounts for 0.11% of the portfolio, ranked #135.

Degroof Petercam Asset Management first reported a position in RMD in Q4 2023 and has held it in 2 quarters since. 719 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Degroof Petercam Asset Management held 46,527 shares of ResMed worth $9.21M as of Q1 2024.
  • Degroof Petercam Asset Management sold 4,700 ResMed shares in Q1 2024, an estimated $861K.
  • ResMed made up 0.11% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #135 holding.
  • Degroof Petercam Asset Management first reported a position in ResMed in Q4 2023 and has held it in 2 quarters since.
  • 719 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.